Amneal Pharmaceuticals announces the addition of ready-to-use IV bags to its biosciences portfolio. Offering products such as biosimilars and multi-source injectables in convenient presentations like bags and prefilled syringes helps to improve availability and selection. With three ready-to-use IV bag products recently launched (calcium gluconate, dexmedetomidine, and magnesium sulfate), Amneal plans to follow with three more (esmolol, ropivacaine, and tranexamic acid).